RT Journal Article
SR Electronic
T1 The efficiency of dynamic regional lockdown approach in controlling the COVID-19 epidemic. Insights from the agent-based epidemiological model for Poland
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.06.21263031
DO 10.1101/2021.09.06.21263031
A1 Zieliński, Jakub
A1 Gruziel-Słomka, Magdalena
A1 Nowosielski, Jȩdrzej M.
A1 Bartczuk, Rafał P.
A1 Niedzielewski, Karol
A1 Semeniuk, Marcin
A1 Górski, Łukasz
A1 Kisielewski, Jan
A1 Moszyński, Antoni
A1 Radwan, Maciej
A1 Kaczorek, Artur
A1 Rakowski, Franciszek
YR 2021
UL http://medrxiv.org/content/early/2021/09/24/2021.09.06.21263031.abstract
AB In this work properties of the dynamic regional lockdown approach to suppress the COVID-19 epidemic spread in Poland were investigated. In particular, an agent based model was used with the aim to indicate an optimal lockdown strategy, defined here as the one which minimizes mean lockdown time over regional unit provided health service is not overwhelmed. With this approach the lockdown extent was also considered by varying restrictions between complete regional school closure and/or significant social distancing in semi-public spaces. In result, a cooperative effect was discovered in the case when closure of schools was accompanied by severe restrictions of social contacts in semi-public spaces. Moreover, the regional lockdown approach implemented here on the level of counties (units of population around 100k) proofed to be successful, that is allowed to identify optimal entrance and release thresholds for lockdown. The authors believe that until significant portion of population is vaccinated such a strategy might be applied.Competing Interest StatementMixed competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: all authors had financial support from the Ministry of Science and Higher Education of Poland to the University of Warsaw; MG-S, JMN, RPB, KN, MS, ŁG, JK, AM, MR, AK, and FR since September 1, 2020, took part in meetings of the Team for monitoring and forecasting the course of the COVID-19 epidemic in the Republic of Poland, free of charge, as experts advising the Minister of Health; FR was paid for lectures from Polish Pharmacoeconomic Society and Noble Securities S.A., got support for attending meetings and/or travel from the University of Warsaw, as well as since September 1, 2021 he is paid expert in Chancellery of the Prime Minister of Poland; no other relationships or activities that could appear to have influenced the submitted work.Funding StatementThe study was conducted as part of the ICM epidemiological model development project, funded by the Ministry of Science and Higher Education with grant 51/WFSN/2020 to the University of Warsaw. The funders had no role in conducting this research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study describes mathematical modeling and is not appropriate for evaluation by an ethics committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data available.